268 related articles for article (PubMed ID: 18270218)
1. The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research.
Merrick BA
Brief Funct Genomic Proteomic; 2008 Jan; 7(1):35-49. PubMed ID: 18270218
[TBL] [Abstract][Full Text] [Related]
2. Toxicoproteomics: new paradigms in toxicology research.
George J; Singh R; Mahmood Z; Shukla Y
Toxicol Mech Methods; 2010 Sep; 20(7):415-23. PubMed ID: 20175663
[TBL] [Abstract][Full Text] [Related]
3. The role of toxicoproteomics in assessing organ specific toxicity.
Merrick BA; Witzmann FA
EXS; 2009; 99():367-400. PubMed ID: 19157068
[TBL] [Abstract][Full Text] [Related]
4. Toxicoproteomics: proteomics applied to toxicology and pathology.
Wetmore BA; Merrick BA
Toxicol Pathol; 2004; 32(6):619-42. PubMed ID: 15580702
[TBL] [Abstract][Full Text] [Related]
5. Proteomics: recent applications and new technologies.
Elrick MM; Walgren JL; Mitchell MD; Thompson DC
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
[TBL] [Abstract][Full Text] [Related]
6. Proteomics in mechanistic toxicology: history, concepts, achievements, caveats, and potential.
Rabilloud T; Lescuyer P
Proteomics; 2015 Mar; 15(5-6):1051-74. PubMed ID: 25164579
[TBL] [Abstract][Full Text] [Related]
7. Toxicoproteomics in liver injury and inflammation.
Merrick BA
Ann N Y Acad Sci; 2006 Sep; 1076():707-17. PubMed ID: 17119248
[TBL] [Abstract][Full Text] [Related]
8. Toxicoproteomics in human health and disease: an update.
Suman S; Mishra S; Shukla Y
Expert Rev Proteomics; 2016 Dec; 13(12):1073-1089. PubMed ID: 27813434
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers: mining the biofluid proteome.
Veenstra TD; Conrads TP; Hood BL; Avellino AM; Ellenbogen RG; Morrison RS
Mol Cell Proteomics; 2005 Apr; 4(4):409-18. PubMed ID: 15684407
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
11. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
12. Toxicoproteomics -- a new preclinical tool.
Bandara LR; Kennedy S
Drug Discov Today; 2002 Apr; 7(7):411-8. PubMed ID: 11916571
[TBL] [Abstract][Full Text] [Related]
13. Proteomics technologies for the global identification and quantification of proteins.
Brewis IA; Brennan P
Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
[TBL] [Abstract][Full Text] [Related]
14. 2D electrophoresis-based expression proteomics: a microbiologist's perspective.
Sá-Correia I; Teixeira MC
Expert Rev Proteomics; 2010 Dec; 7(6):943-53. PubMed ID: 21142894
[TBL] [Abstract][Full Text] [Related]
15. Development of a pharmaceutical hepatotoxicity biomarker panel using a discovery to targeted proteomics approach.
Collins BC; Miller CA; Sposny A; Hewitt P; Wells M; Gallagher WM; Pennington SR
Mol Cell Proteomics; 2012 Aug; 11(8):394-410. PubMed ID: 22527513
[TBL] [Abstract][Full Text] [Related]
16. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
17. Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification.
Harel M; Oren-Giladi P; Kaidar-Person O; Shaked Y; Geiger T
Mol Cell Proteomics; 2015 Apr; 14(4):1127-36. PubMed ID: 25624350
[TBL] [Abstract][Full Text] [Related]
18. A new light of proteomics in cell biology and toxicology.
Qiao T; Wang X
Cell Biol Toxicol; 2019 Aug; 35(4):289-291. PubMed ID: 31428956
[TBL] [Abstract][Full Text] [Related]
19. In vitro toxicoproteomic analysis of A549 human lung epithelial cells exposed to urban air particulate matter and its water-soluble and insoluble fractions.
Vuong NQ; Breznan D; Goegan P; O'Brien JS; Williams A; Karthikeyan S; Kumarathasan P; Vincent R
Part Fibre Toxicol; 2017 Oct; 14(1):39. PubMed ID: 28969663
[TBL] [Abstract][Full Text] [Related]
20. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.
Qian WJ; Jacobs JM; Liu T; Camp DG; Smith RD
Mol Cell Proteomics; 2006 Oct; 5(10):1727-44. PubMed ID: 16887931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
